Regeneron
PITTSBURG, Pa. (WHTM) — As scientists are wondering if an effective treatment for COVID will work on the new omicron variant, UPMC is talking about new research that could treat infected patients more efficiently.
UPMC performed the first and largest clinical trial in the world to compare different methods of administering monoclonal antibodies.
“What we found is that subcutaneous injections of Regeneron’s COVID-19 treatment worked essentially as effective as the IV at keeping our patients alive and out of the hospital,” said Dr. Erin McCreary, infectious diseases pharmacist at UPMC and clinical assistant professor in Pitt’s School of Medicine.
McCreary says a shot instead of an infusion of the same dose will allow hospitals to treat twice as many patients.
https://www.abc27.com/news/health/coronavirus/coronavirus-pennsylvania/upmc-to-study-omicron-variant-announces-new-research-guiding-covid-19-treatment/